Plain-English translation of NCT07891429 on ClinicalTrials.gov ↗ · Source last updated · Translation generated · How we translate trials
This is a long-term research study designed to help doctors catch early signs of memory loss and Alzheimer's disease before symptoms become severe. Researchers will collect information from 3,000 older volunteers through cognitive assessments, blood tests, genetic screening, and advanced brain imaging like MRI and PET scans. The goal is to better understand how the disease develops and find the best ways to prevent or treat it early.
Alzheimer's disease is becoming increasingly common in China's aging population, and doctors know that catching the disease early—even before people notice memory problems—offers the best chance to slow it down or prevent it. This study aims to develop better screening methods and understand which blood markers and brain changes signal early disease, so treatment can start sooner.
You likely qualify if…
You likely don't qualify if…
If you join this study, you will have a detailed baseline visit where you complete memory and thinking tests, provide blood samples, and may have a spinal fluid sample collected. You will also undergo brain imaging with MRI and possibly PET scans to look for early signs of disease. After the initial visit, you will return for annual follow-up appointments over several years to repeat some tests and provide updates on your health. All participants receive comprehensive cognitive testing and genetic screening; some will also have EEG monitoring, additional MRI sequences, and tau or amyloid PET imaging depending on study protocols.
AI-generated summary from trial data · Oct 25, 2026 · Not medical advice
China